CTCF and endometrial cancer: We report for the first time, that CTCF and CTCFL/BORIS seem to diverge in the different subtypes of endometrial cancer; with CTCF mutations occurring in endometrioid subtype and aberrant expression of CTCFL/BORIS being defined to cases of non-endometrioid subtype.